Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -1.584% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: COc1ccc([N+](=O)[O-])cc1NS(=O)(=O)c1ccc(C)cc1
b: Cc1ccc(NC2CCCN(C(=O)c3c(C)noc3C)C2)cc1C
Answer: b. Cc1ccc(NC2CCCN(C(=O)c3c(C)noc3C)C2)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NC2CCCN(C(=O)c3c(C)noc3C)C2)cc1C
Cc1ccc(NC2CCCN(C(=O)c3c(C)noc3C)C2)cc1C
[3-(3,4-dimethylanilino)piperidin-1-yl]-(3,5-dimethyl-1,2-oxazol-4-yl)methanone